BDgene
Latest round
- Series C
Last raised
- Mar 2026
Total raised
- $37M
Investors
- 13
About BDgene
Based in Hangzhou, China and founded in 2018, Hangzhou BDgene Therapeutics Co., dba BDgene, operates as a biotechnology company which focuses on drug development for gene therapy. The company's founder, Yujia Cai, is a member of the Systems Biomedicine Committee of the Chinese Society of Bioengineering. BDgene was initially headquartered in Shanghai but later relocated to Hangzhou in March 2026; the Shanghai base, however, still operates as a R&D center of the company., some of which, including HSK-BD111, an antiviral gene-editing drug for the treatment of viral keratitis, and Thalassemia-BD211 for the treatment of transfusion-dependent ß-thalassemia, have reached final phases of clinical trials. The company generates revenue from developing cell and gene therapy drugs.
Who invested in BDgene
13 investors across 3 rounds
See all investors in BDgene
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about BDgene
Who invested in BDgene?
BDgene has 13 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BDgene raised?
BDgene has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did BDgene last raise money?
BDgene's most recent round on record is a Series C, in Mar 2026.
What does BDgene do?
Based in Hangzhou, China and founded in 2018, Hangzhou BDgene Therapeutics Co.
Where is BDgene headquartered?
BDgene is headquartered in Hangzhou, China.
Which VCs invest in companies like BDgene?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at BDgene's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like BDgene? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.